News & ViewsNewslettersContactBecome a Research Patient
DHRHealth Institute for Research and Development

Clinical Trial

The Texas Hepatocellular Carcinoma Consortium (THCCC); Risk Stratification For and Early Detection of Liver Cancer (U01)

Study Status:

Not Yet Recruiting

Please contact us for more information or to learn if you are eligible to participate.

Study Purpose:

The purpose of this study is the identification of risk factors and early detection of HCC with emphasis on the high-risk Cirrhotic patient population.


Principal Investigator
Rashmee Patil, MD
Baylor College of Medicine
Type of Trial
DHRHealth Institute for Research and Development
5323 S. McColl Rd., Edinburg, TX 78539
(956) 362-2390
© 2022 DHR Health Institute for Research & Development | All Rights Reserved | Terms & Conditions | Site By: KangoMedia
chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank